Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
Once-weekly (OW) subcutaneous semaglutide is a GLP-1RA supported for the treatment of type 2 diabetes (T2D) at dosages of 0.5 mg and 1.0 mg....